- Latest week
- 10 Jul 2026
- Close
- 21.215000
- Fair value
- 22.003487
- Next-week expectancy
- Undecided 52.26%
PFE Chart Pack
Pfizer Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, PFE fell 5.27%, moving from 22.39 to 21.21. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 9 of the last 12 weeks. Relative Strength is -3.84 and has softened across the 12-week window. Market Dynamics is -1.05 on the latest week. Next-week expectancy is undecided at 52.26% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 21.21
- 12-Week Change
- -5.27%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.26%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -3.84
- Market Dynamics
- -1.05
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 21.21
- 12-Week Change
- -5.27%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.26%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -3.84
- Market Dynamics
- -1.05
Over the latest 12 completed weeks ending 2026-07-10, PFE fell 5.27%, moving from 22.39 to 21.21. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 9 of the last 12 weeks. Relative Strength is -3.84 and has softened across the 12-week window. Market Dynamics is -1.05 on the latest week. Next-week expectancy is undecided at 52.26% based on similar historical setup states.
Industry Peers
Germany equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| GIS Gilead Sciences, Inc. | GER | 10 Jul 2026 | 115.02 | 120.80 | 112.54 | 114.86 | -0.14% |
| SNW Sanofi | GER | 10 Jul 2026 | 76.55 | 77.11 | 74.43 | 76.12 | -0.56% |
| BRM Bristol-Myers Squibb Company | GER | 10 Jul 2026 | 50.60 | 51.06 | 49.58 | 50.20 | -0.79% |
| JNJ Johnson & Johnson | GER | 10 Jul 2026 | 229.50 | 235.65 | 225.25 | 226.15 | -1.46% |
| NOV Novo Nordisk A/S | GER | 10 Jul 2026 | 43.90 | 44.19 | 42.33 | 43.13 | -1.77% |
| AMG Amgen Inc. | GER | 10 Jul 2026 | 325.40 | 327.65 | 316.00 | 318.55 | -2.11% |
| RHO Roche Holding AG | GER | 10 Jul 2026 | 376.40 | 377.40 | 363.60 | 368.00 | -2.23% |
| LLY Eli Lilly and Company | GER | 10 Jul 2026 | 1062.80 | 1090.80 | 1036.80 | 1037.80 | -2.35% |
| GS71 GSK plc | GER | 10 Jul 2026 | 23.70 | 23.91 | 22.92 | 22.98 | -3.04% |
| NOT NOVARTIS AG N | GER | 10 Jul 2026 | 139.40 | 139.68 | 134.48 | 134.60 | -3.44% |
| BAYN Bayer Aktiengesellschaft | GER | 10 Jul 2026 | 53.06 | 53.78 | 49.36 | 50.12 | -5.54% |